News
04-12-2012, 01:10 AM
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that breast cancer cells that metastasize to the lung express a higher level of the protein peroxiredoxin 2 (PRDX2). The study suggests that the modulation of the levels of this protein could be a new therapeutic strategy to prevent lung metastases...
More... (http://www.medicalnewstoday.com/releases/243955.php)
More... (http://www.medicalnewstoday.com/releases/243955.php)